ReviewThe World Allergy Organization journal2021
Expert consensus on the use of omalizumab in chronic urticaria in China.
Open access · goldAbstract readReview
In one paragraph
Review in The World Allergy Organization journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices Study.Dermatology and therapy · 2026Article
- Advancements and challenges in the management of chronic inducible urticaria.Frontiers in immunology · 2026Review
- Analysis of Predictors of Response Degree to Omalizumab in 124 Patients with Chronic Spontaneous Urticaria.Clinical, cosmetic and investigational dermatology · 2026Article
- Characterization and Anti-Allergic Mechanisms of Bioactive Compounds in a Traditional Chinese Medicine Prescription Using UHPLC-Q-TOF-MS/MS, Network Pharmacology and Computational Simulations.Pharmaceuticals (Basel, Switzerland) · 2025Article
- The patient perspective on use of Omalizumab in the in-hospital setting.Irish journal of medical science · 2025Article
- Changes in Clinical Trials of Dermatological Drugs in Mainland China Between 2016 and 2022: A Narrative Review.Therapeutic innovation & regulatory science · 2025Review
- A retrospective analysis of factors influencing response to omalizumab treatment in Indian patients with antihistamine refractory chronic spontaneous urticaria.Asia Pacific allergy · 2025Article
- Efficacy and Mechanism of Acupoint Catgut Embedding in the Treatment of Chronic Spontaneous Urticaria: Protocol for a Randomized Double-Blind Placebo-Controlled Trial.JMIR research protocols · 2024Article
- Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study.The journal of allergy and clinical immunology. Global · 2024Article
- Meta-analysis of the adoption of omalizumab in the treatment of pediatric allergic diseases.Heliyon · 2024Article
- Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review.World journal of pediatrics : WJP · 2024Review
- Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study.International archives of allergy and immunology · 2024Observational
- Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome.Clinical, cosmetic and investigational dermatology · 2024Article
- Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients.Acta dermato-venereologica · 2023Article
- Omalizumab's efficacy and safety against chronic spontaneous urticaria.The World Allergy Organization journal · 2023Article
- Integrated Bioinformatics and Validation Reveal IL1B and Its Related Molecules as Potential Biomarkers in Chronic Spontaneous Urticaria.Frontiers in immunology · 2022Article
- Biologicals in Treatment of Chronic Urticaria: A Narrative Review.Indian dermatology online journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
49 authors at 20 institutions in 2 countries.
Zuotao ZhaoDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Tao CaiDepartment of Dermatology and Venerology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hong ChenDepartment of Dermatology and Venerology, Tianjin People's Hospital, Tianjin Union Medical Center, Tianjin, China.
Liuqing ChenDepartment of Dermatology and Venerology, Wuhan No.1 Hospital, Wuhan, China.
Yudi ChenDepartment of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xiang GaoDepartment of Allergy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Xinghua GaoDepartment of Dermatology and Venerology, The First Hospital of China Medical University, Shenyang, China.
Songmei GengDepartment of Dermatology and Venerology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yinshi GuoDepartment of Allergy, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Fei HaoDepartment of Dermatology and Venerology, The Third Affiliated Hospital of Chongqing Medicine University, Chongqing, China.
Guodong HaoDepartment of Allergy, Tangshan Gongren Hospital, Tangshan, China.
Yan HuDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Hongzhong JinDepartment of Dermatology and Venerology, Peking Union Medical College Hospital, Chinese Academy Medical Science, Peking Union Medical College, Beijing, China.
Zhehu JinDepartment of Dermatology and Venerology, Yanbian University Hospital (Yanbian Hospital), Jilin, China.
Chengxin LiDepartment of Dermatology and Venerology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Haili LiDepartment of Ophthalmology, Peking University First Hospital, Beijing, China.
Jie LiDepartment of Dermatology and Venerology, Xiangya Hospital Central South University, Changsha, China.
Yanming LiDepartment of Respiratory and Critical Care Medicine, Bejing Hospital, Beijing, China.
Yunsheng LiangDepartment of Dermatology and Venerology, Dermatology Hospital of Southern Medical University, Guangdong Provincial Dermatology Hospital, Guangdong, China.
Guanghui LiuDepartment of Allergy, ZhongNan Hospital of Wuhan University, Wuhan, China.
Qiang LiuDepartment of Dermatology and Venerology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hai LongDepartment of Dermatology and Venerology, The Second Xiangya Hospital of Central South University, Changsha, China.
Lin MaDepartment of Dermatology and Venerology, Beijing Children's Hospital Capital Medical University, Beijing, China.
Yuanyuan ShangDepartment of Dermatology and Venerology, General Hospital of Ningxia Medical University, Yinchuan, China.
Yuxin SongDepartment of Allergy, Harbin Children's Hospital, Harbin, China.
Zhiqiang SongDepartment of Dermatology and Venerology, The First Affiliated Hospital of Third Military Medical University, Chongqing, China.
Xiangyang SuDepartment of Dermatology and Venerology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Haijing SuiDepartment of Otorhinolaryngology Head and Neck Surgery, Peking University First Hospital, China.
Qing SunDepartment of Dermatology and Venerology, Qilu Hospital, Shandong University, Jinan, China.
Yuemei SunDepartment of Allergy, Yantai Yuhuangding Hospital, Yantai, China.
Jianping TangDepartment of Dermatology and Venerology, Hunan Children's Hospital, Changsha, China.
Xunliang TongDepartment of Respiratory and Critical Care Medicine, Bejing Hospital, Beijing, China.
Huiying WangDepartment of Allergy, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Gang WangDepartment of Dermatology and Venerology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Lianglu WangDepartment of Allergy, Peking Union Medical College Hospital, Beijing, China.
Siqin WangDepartment of Allergy, Henan Provincial Peoples Hospital, Zhengzhou, China.
Li XiangDepartment of Allergy, Beijing Children's Hospital Capital Medical University, Beijing, China.
Ting XiaoDepartment of Dermatology and Venerology, The First Hospital of China Medical University, Shenyang, China.
Zhiqiang XieDepartment of Dermatology and Venerology, Peking University Third Hospital, Beijing, China.
Leping YeDepartment of Paediatrics, Peking University First Hospital, Beijing, China.
Yongmei YuDepartment of Otorhinolaryngology Head and Neck Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Chunlei ZhangDepartment of Dermatology and Venerology, Peking University Third Hospital, Beijing, China.
Litao ZhangDepartment of Dermatology and Venerology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Shuchen ZhangDepartment of Allergy, Tongji Medical College, Huazhong University of Science&Technology, Wuhan, China.
Rui ZhengDepartment of Dermatology and Venerology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Lili ZhiDepartment of Allergy, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Shandong Institute of Respiratory Diseases, Jinan, China.
Wei ZhouDepartment of Paediatrics, Peking University Third Hospital, Beijing, China.
Ying ZouDepartment of Dermatology and Venerology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Marcus MaurerDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Peking University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNCapital Medical University · CNCentral South University · CNQingdao University · CNArmy Medical University · CNChinese PLA General Hospital · CNFirst Hospital of China Medical University · CNHebei Medical University · CNHenan Provincial People's Hospital · CNHuazhong University of Science and Technology · CNHunan Children's Hospital · CNKunming Medical University · CNNingxia Medical University · CNQilu Hospital of Shandong University · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CNSecond Affiliated Hospital of Zhejiang University · CNShandong Provincial QianFoShan Hospital · CNShanghai Jiao Tong University · CNShanxi Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic urticaria (CU) is a debilitating skin disease that lasts for more than 6 weeks with wheals and/or angioedema, including chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). In China, the prevalence of this disease is high, more than 1%, and on the rise. CU has a major impact on the quality of life (QoL) of patients who frequently experience sleep disturbance, depression, and anxiety. Nearly one-third of patients with CSU, in China, are resistant to second-generation H
Indexed as
ChinaChronic inducible urticariaChronic spontaneous urticariaOmalizumabTreatment algorithm
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.